openPR Logo
Press release

Infectious Disease Therapeutics Market Global Growth, Trends, And Forecast -2023 | Major Ket Players are Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharma, Bayer.

01-02-2019 06:36 AM CET | Health & Medicine

Press release from: Market Data Forecast

Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market– GlaxoSmithKline plc (GSK) had introduced a new drug.

Recent Developments

GlaxoSmithKline plc (GSK) had 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products. GlaxoSmithKline (GSK) and Isis Pharmaceuticals Inc. had announced a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new infectious disease therapeutics product against targets for rare and serious diseases.

To know more read: https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/

Market Segmentation

Infectious Disease Therapeutics Market worth was USD 105.13 Billion in 2018 and estimated to reach USD 154.18 Billion by the end of 2023 with a growing potential of 7.96 %.

Report is segmented by

Target Organism

Antibacterial
Antifungal
Antiviral
Antiparasite
Infection type

Bacterial
Viral
Fungal
parasitic
Increase in the geriatric population and increasing healthcare expenditure are some of the key factors driving the growth for the global infectious diseases therapeutics market. Rising healthcare awareness is also fuelling the growth of the global infectious diseases therapeutics market.

Geographical Segmentation:

North America is expected to account the majority share in the market followed by Asia-Pacific and Europe owing to a rising incidence of infectious diseases, and increasing the aging population. Asia-Pacific is projected to account for the highest CAGR over the forecast period owing to increasing government funding in some emerging countries such as India, China.

Key market players in the market are -

Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
View sample and decide:https://www.marketdataforecast.com/market-reports/infectious-Disease-therapeutics-market-1320/request-sample



The scope of the report:

The report gives a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the current market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is measured and the prospects with high growth potential are identified and debated. The major players in the industry are profiled providing insights on their financial performance, market position, and the growth strategies. Comparative analysis on key strategically activities of the market players delineating the key developments like mergers and acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also provides a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033, India.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Therapeutics Market Global Growth, Trends, And Forecast -2023 | Major Ket Players are Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharma, Bayer. here

News-ID: 1465141 • Views:

More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significant growth rate
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024. The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations
Antimicrobial Coatings Market expected to witness a significant growth rate of 11% by 2029.
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029. It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively
End-User Computing Market Sees Explosive Growth Globally
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period. Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user
Smart Homes Market Size, Share, Growth Report 2024-2029
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period. Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and